Leitner Eva, Bozic Michael, Kienesberger Sabine, Cosic Amar, Landt Olfert, Högenauer Christoph, Kessler Harald H
Diagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Austria.
Diagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Austria.
Clin Microbiol Infect. 2022 May;28(5):690-694. doi: 10.1016/j.cmi.2021.09.017. Epub 2021 Sep 25.
Toxin-producing Klebsiella oxytoca causes antibiotic-associated haemorrhagic colitis (AAHC). The disease-relevant cytotoxins tilivalline and tilimycine produced by certain K. oxytoca isolates are encoded by the non-ribosomal peptide synthetase genes A (npsA) and B (npsB). In this study, the new LightMix® Modular kit for the detection of relevant K. oxytoca sensu lato (s.l.) toxin genes was evaluated.
DNA was extracted on the automated EMAG® platform. Amplification was done on the Light Cycler® 480 II instrument. In total, 130 residual faecal specimens collected from patients with antibiotic-associated diarrhoea were studied to determine the clinical sensitivity and specificity. Toxigenic culture served as reference method.
With the new kit, the limit of detection was 15 CFU/mL for all targets. For the pehX target specific to K. oxytoca s.l., 65 of 130 clinical specimens were positive, while toxin-specific targets (npsA/npsB) were positive in 47 of 130. The npsA/npsB PCR targets showed a clinical sensitivity of 100% (95%CI 80.5-100%) and a specificity of 73.5% (95%CI 64.3-81.3%) with a positive predictive value of 16.5% (95%CI 12.7-21.2%) and a negative predictive value of 100%.
Compared with culture, additional clinical specimens positive for K. oxytoca s.l. were detected with real-time PCR. The specificity of the toxin targets appears moderate due to the inferior sensitivity of the culture-based reference method. Since the developed assay is highly sensitive, it may be used as first-line method to improve the diagnosis of AAHC.
产毒素的产酸克雷伯菌可导致抗生素相关性出血性结肠炎(AAHC)。某些产酸克雷伯菌分离株产生的与疾病相关的细胞毒素tilivalline和tilimycine由非核糖体肽合成酶基因A(npsA)和B(npsB)编码。在本研究中,对用于检测相关产酸克雷伯菌复合群(s.l.)毒素基因的新型LightMix®模块化试剂盒进行了评估。
在自动化EMAG®平台上提取DNA。在Light Cycler® 480 II仪器上进行扩增。总共研究了130份从抗生素相关性腹泻患者收集的粪便残余标本,以确定临床敏感性和特异性。产毒培养作为参考方法。
使用新型试剂盒,所有靶标的检测限为15 CFU/mL。对于产酸克雷伯菌复合群特有的pehX靶标,130份临床标本中有65份呈阳性,而毒素特异性靶标(npsA/npsB)在130份中有47份呈阳性。npsA/npsB PCR靶标的临床敏感性为100%(95%CI 80.5 - 100%),特异性为73.5%(95%CI 64.3 - 81.3%),阳性预测值为16.5%(95%CI 12.7 - 21.2%),阴性预测值为100%。
与培养相比,实时PCR检测出了更多产酸克雷伯菌复合群阳性的临床标本。由于基于培养的参考方法敏感性较低,毒素靶标的特异性似乎适中。由于所开发的检测方法具有高度敏感性,它可作为一线方法用于改善AAHC的诊断。